21,099 Shares in iRhythm Technologies $IRTC Acquired by Knights of Columbus Asset Advisors LLC

Knights of Columbus Asset Advisors LLC acquired a new position in shares of iRhythm Technologies (NASDAQ:IRTC) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 21,099 shares of the company’s stock, valued at approximately $2,398,000. Knights of Columbus Asset Advisors LLC owned 0.06% of iRhythm Technologies at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in IRTC. Versant Capital Management Inc boosted its holdings in iRhythm Technologies by 123.2% during the third quarter. Versant Capital Management Inc now owns 221 shares of the company’s stock worth $25,000 after buying an additional 122 shares in the last quarter. Covestor Ltd grew its position in iRhythm Technologies by 44.8% during the third quarter. Covestor Ltd now owns 417 shares of the company’s stock valued at $47,000 after buying an additional 129 shares during the period. Harbor Investment Advisory LLC acquired a new stake in iRhythm Technologies during the second quarter valued at $50,000. Assetmark Inc. increased its holdings in iRhythm Technologies by 30.1% in the first quarter. Assetmark Inc. now owns 821 shares of the company’s stock valued at $97,000 after buying an additional 190 shares in the last quarter. Finally, Sterling Capital Management LLC increased its holdings in iRhythm Technologies by 842.2% in the third quarter. Sterling Capital Management LLC now owns 1,093 shares of the company’s stock valued at $124,000 after buying an additional 977 shares in the last quarter.

iRhythm Technologies Price Performance

Shares of NASDAQ IRTC opened at $88.68 on Thursday. The firm has a market cap of $2.98 billion, a PE ratio of -75.79 and a beta of 1.39. The firm has a fifty day moving average of $112.99 and a 200 day moving average of $120.57. The company has a debt-to-equity ratio of 3.68, a quick ratio of 3.45 and a current ratio of 3.57. iRhythm Technologies has a one year low of $82.85 and a one year high of $192.47.

iRhythm Technologies (NASDAQ:IRTC) last posted its quarterly earnings data on Thursday, November 5th. The company reported $0.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.80. iRhythm Technologies had a negative net margin of 4.52% and a positive return on equity of 26.88%. The business had revenue of $221.59 million for the quarter, compared to the consensus estimate of $222.23 million. During the same period last year, the firm posted ($0.06) earnings per share. The company’s revenue was up 14.9% compared to the same quarter last year. As a group, research analysts predict that iRhythm Technologies will post 0.79 EPS for the current fiscal year.

Analysts Set New Price Targets

IRTC has been the topic of several recent analyst reports. Needham & Company LLC lowered their target price on shares of iRhythm Technologies from $194.00 to $165.00 and set a “buy” rating on the stock in a research note on Friday, November 6th. Wells Fargo & Company cut their price target on iRhythm Technologies from $150.00 to $135.00 and set an “overweight” rating for the company in a research note on Friday, November 6th. Stephens cut their price target on iRhythm Technologies from $160.00 to $120.00 and set an “overweight” rating for the company in a research note on Wednesday. BTIG Research reduced their price target on iRhythm Technologies from $185.00 to $170.00 and set a “buy” rating for the company in a report on Friday, November 6th. Finally, Citigroup downgraded iRhythm Technologies from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $157.00 to $124.00 in a research report on Friday, November 6th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $164.07.

iRhythm Technologies Profile

iRhythm Technologies is a medical technology company that develops digital solutions for detecting and monitoring heart rhythm disorders. Its services combine wearable electrocardiogram (ECG) devices with cloud-based data analysis and clinical reporting to help healthcare professionals assess patients for conditions such as cardiac arrhythmias. The company’s Zio product line includes wearable ECG monitors, such as Zio XT, which records a patient’s heart activity during an extended monitoring period. iRhythm also offers Zio AT, a monitoring service designed to provide clinicians with ECG data during the monitoring period.